A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer’s disease

By sjmartinez • September 6, 2024

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease. Alzheimers Res Ther. 2024 Sep 5;16(1):197. doi: 10.1186/s13195-024-01552-2. PMID: 39238036.

Tags: 5xFAD, Aerobic glycolysis, Alzheimer’s disease, Geriatrics, Glucose metabolism, GRECC, PDH, PDHK, Publications, Pyruvate dehydrogenase, Pyruvate dehydrogenase kinase, Veterans Administration

Advancing aging biomarkers and intervention discovery at the TimePie Longevity Forum

Ying K, Bie J, Chen G, Cuervo AM, Deng H, Dong L, Furman D, Gorbunova V, Han JJ, Horvath S, Ji G, Jiang N, Mostoslavsky[...]

Workplace Violence in Home Health: Staff and Leadership Experiences and Strategies

Leland NE, Wong C, Prusynski RA, Bettger JP, Shore A, Lam J, Mroz TM, Mathis L, Saliba D. Workplace Violence in Home Health: Staff and[...]

Volunteering and resilience in wartime: evidence from two population-based studies in Israel

Merkin SS, Orenstein L, Fuchs G, Efrat-Treister D. Volunteering and resilience in wartime: evidence from two population-based studies in Israel. BMC Public Health. 2026 Aug[...]